Dr. Yuk Yin Sham

Center for Drug Design, Senior Graduate faculty, Bioinformatics and Computational Biology Program

Assistant Professor and Assistant Director

Minnesota Supercomputing Institute

University of Minnesota, USA

Associate Fellow



1999 Ph.D., Department of Chemistry, University of Southern California, USA

1993 B.Sc., Department of Chemistry, Florida International University, USA

Publications (selected)

  1. Chen YL, Tang J, Kesler MJ, Sham YY, Vince R, Geraghty RJ, Wang Z, “The Design, Synthesis and Biological Evaluations of C-6 or C-7 Substituted 2-Hydroxylisoquinoline-1,3-diones as Inhibitors of Hepatitis C Virus” Bioorganic & Medicinal Chemistry, 20: 467–479 (2012).
  2. Palpant NJ, Houang EM, Mundada L, Sham YY, Metzger JM “pH responsive titratable performance of histidine-modified cardiac troponin I attributed to imidazole ionization” Biophysical Journal, 102: 1570-1579 (2012).
  3. Li L, Sham YY, Elmquist WF “pH dependent transport of premetrexed in breast cancer resistant protein” Drug Metabolism and Disposition, 39: 1478-1485 (2011).
  4. Tang J, Maddali K, Metifiot M, Sham YY, Vince R, Pommier Y, Wang Z “3-Hyroxypyrimidine-2,4-diones as novel scaffold for HIV integrase inhibitor design” Journal Medicinal Chemistry, 54:2282-2292 (2011).
  5. Tang J, Maddali K, Dreis CD, Sham YY, Vince R, Pommier Y, Wang Z “N-3 hydroxylation of pyrimidine-2,4-diones yields dual inhibitors of HIV reverse transcriptase and integrase” ACS Medicinal ChemistryLetters, 2: 63-67 (2011).
  6. Chen L, Wilson DJ, Xu Y, Aldrich CC, Felczak K, Sham YY, Pankiewicz K “Triazole-linked inhibitors of inosine monophosphate dehydrogenases from human and Mycobacterium tuberculosisJournal Medicinal Chemistry, 53: 4768-4778(2010).
  7. Tang J, Maddali K, Pommier Y, Sham YY, Wang Z “Scaffold rearrangement of dihydroxypyrimidine integrase inhibitors: Binding model revisited” Bioorganic & Medicinal Chemistry Letters,20:2037-2048 (2010).
  8. Ding L, Sham YY, Vince R “Design, asymmetric synthesis and bioevaluation of pseudo-symmetric sulfoximine inhibitors against HIV-1 protease” Bioorganic & Medicinal Chemistry, 18: 2037-2048 (2010).
  9. Petrelli R, Sham YY, Chen L, Felczak K, Bennett EM, Aldrich C, Wilson DW, Yu JS, Cappellacci L, Franchetti P, Grifantini M, Mazzola F, Di Stefano M, Magni G, Pankiewicz K “Selective inhibition of NAD kinase by dinucleoside disulfide NAD mimics” Bioorganic & Medicinal Chemistry, 17:5656-5664 (2009).
  10. Nesmelova IV, Sham Y,Gao J,Mayo KH “CXC and CC Chemokines from mixed heterodimers: Association free energies from MD simulations and experimental correlations” Journal of Biological Chemistry, 283: 24155-24166 (2008).
  11. Chou T, Sham YY, Wagner CR The C-terminal loop of histidine triad nucleotide binding protein 1 (Hint1) mediates substrate specificity Biochemistry, 46:13074-13079 (2007).
  12. Li M, He Z, Ermakova S, Zheng D, Tang F, Cho YY, Zhu F, Ma WY, Sham Y, Rogozin EA, Bode AM, Cao Y, Dong Z Direct inhibition of insulin-like growth factor-1 receptor kinase activity by (-)-epigallocatechin-3-gallate regulates cell proliferation and transformation Cancer Epidemiology Biomarkers & Prevention, 16: 598-605 (2007).
  13. Xing C, Wang L, Tang X, Sham YY “Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1” Bioorganic & Medicinal Chemistry, 15:2167-2176 (2007).
  14. Kumar V, Locuson C, Sham Y, Tracy T “Amiodarone-analog dependent effects on CYP2C9-mediated metabolism and kinetic profiles” Drug Metabolism and Disposition, 34: 1688-1696 (2006).
  15. Zhang Y, Sham YY, Rajamani R, Gao J, Portoghese PS “Homology modeling of the mu opioid receptor built in a complete membrane-aqueous system” ChemBioChem, 6: 853-859 (2005).

Profile Details: